An extra 60 million doses of the Pfizer/BioNTech vaccine have been secured by the UK government to help support the booster COVID-19 vaccination programme beginning from the Autumn.
To protect the most vulnerable ahead of the winter, the government is preparing for a booster programme based on clinical need to ensure people have the strongest possible protection against COVID-19.
The additional Pfizer/BioNTech jabs will be used alongside other approved COVID-19 vaccines for the booster programme.
This comes as new data from Public Health England shows that one dose of a COVID-19 vaccine reduces household transmission of the virus by up to half.
Health and Social Care Secretary Matt Hancock said: “Our vaccination programme is bringing back our freedom, but the biggest risk to that progress is the risk posed by a new variant. We’re working on our plans for booster shots, which are the best way to keep us safe and free while we get this disease under control across the whole world.
“These further 60 million doses will be used, alongside others, as part of our booster programme from later this year, so we can protect the progress that we’ve all made.”
Ben Osborn, Country Manager at Pfizer UK, said: “By more than doubling our supply commitment to the UK, we are delighted to support the ongoing rollout of the UK immunisation programme and help the government in its efforts to address the pandemic. Along with our partner BioNTech, we are working relentlessly to support vaccination campaigns worldwide and, based on current projections, believe we can deliver more than 2.5 billion doses of our vaccine globally by the end of 2021.”